Critical Path to Public Private Partnerships

项目总结 C-Path是在关键路径倡议的赞助下于2005年创建的，以催化 领导利益相关者团队在医疗创新和监管科学方面的进展 学术界、产业界、政府和倡导组织，并促进共享 数据、知识和专业知识，以便产生健全的、基于共识的科学。C-Path的 成功的包括创建合作财团，新药资格 开发工具(DDT)、适合用途的疾病进展模型的认可和 临床试验模拟工具，新数据标准和数据库的生成，以及 创建促进监管科学的教育倡议。通过重新融资C-Path 将能够继续发展关键的公私伙伴关系并推动 在研究、教育和推广方面的创新、协作项目，以促进医疗 产品创新，加速医疗产品开发、制造、 和转化疗法，并提高医疗产品的安全性。

PROJECT SUMMARY C-Path was created in 2005 under the auspices of the Critical Path Initiative to catalyze advances in medical innovation and regulatory science by leading teams of stakeholders from academia, industry, government, and advocacy organizations and promoting the sharing of data, knowledge and expertise in order to produce sound, consensus-based science. C-Path's successes include the creation of cooperative consortia, the qualification of new drug development tools (DDTs), the endorsement of fit-for-purpose disease progression models and clinical trial simulation tools, the generation of new data standards and databases, and the creation of educational initiatives that advance regulatory science. With renewed funding C-Path will be able to continue developing Critical Path Public-Private Partnerships and advancing innovative, collaborative projects in research, education, and outreach for fostering medical product innovation, enabling the acceleration of medical product development, manufacturing, and translational therapeutics, and enhancing medical product safety.